Author:
Siddiqui Maria Tariq,Price Allyson,Ferrajoli Alessandra,Borthakur Gautam
Reference22 articles.
1. B and T cell prolymphocytic leukaemia;Cross;Best Pract. Res. Clin. Haematol.,2019
2. Complete response to alemtuzumab in a patient with B prolymphocytic leukemia [7];Chaar;Am. J. Hematol.,2007
3. Idelalisib-rituximab induces durable remissions in TP53 disrupted B-PLL but results in significant toxicity: updated results of the UK-wide compassionate use programme;Eyre;Br. J. Haematol.,2019
4. Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysis;Eyre;Br. J. Haematol.,2019
5. J. Swerdlow, S.H.; Campo, E.; Harris, N.L.; Jaffe, E.S.; Pileri, S.A.; Stein, H.; Thiele, J.; Vardiman, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed., 2008.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献